PRIORITIZING CHEMICAL CONSTITUENTS IN TOBACCO PRODUCTS AND SMOKE TO PREDICT DEVELOPMENTAL OSTEOTOXICITY IN HUMAN EMBRYONIC STEM CELLS by Madrid, Joseph
California State University, San Bernardino 
CSUSB ScholarWorks 
Electronic Theses, Projects, and Dissertations Office of Graduate Studies 
12-2018 
PRIORITIZING CHEMICAL CONSTITUENTS IN TOBACCO 
PRODUCTS AND SMOKE TO PREDICT DEVELOPMENTAL 
OSTEOTOXICITY IN HUMAN EMBRYONIC STEM CELLS 
Joseph Madrid 
joseph.madrid@csusb.edu 
Follow this and additional works at: https://scholarworks.lib.csusb.edu/etd 
 Part of the Cell Biology Commons, and the Developmental Biology Commons 
Recommended Citation 
Madrid, Joseph, "PRIORITIZING CHEMICAL CONSTITUENTS IN TOBACCO PRODUCTS AND SMOKE TO 
PREDICT DEVELOPMENTAL OSTEOTOXICITY IN HUMAN EMBRYONIC STEM CELLS" (2018). Electronic 
Theses, Projects, and Dissertations. 767. 
https://scholarworks.lib.csusb.edu/etd/767 
This Thesis is brought to you for free and open access by the Office of Graduate Studies at CSUSB ScholarWorks. It 
has been accepted for inclusion in Electronic Theses, Projects, and Dissertations by an authorized administrator of 
CSUSB ScholarWorks. For more information, please contact scholarworks@csusb.edu. 
 
 
PRIORITIZING CHEMICAL CONSTITUENTS IN TOBACCO PRODUCTS AND 
SMOKE TO PREDICT DEVELOPMENTAL OSTEOTOXICITY IN HUMAN 
EMBRYONIC STEM CELLS 
 
 
A Thesis 
Presented to the 
Faculty of 
California State University, 
San Bernardino 
 
 
In Partial Fulfillment 
of the Requirements for the Degree 
Master of Science in 
Biology 
 
 
by 
Joseph Valenzuela Madrid 
December 2018 
 
 
 
PRIORITIZING CHEMICAL CONSTITUENTS IN TOBACCO PRODUCTS AND 
SMOKE TO PREDICT DEVELOPMENTAL OSTEOTOXICITY IN HUMAN 
EMBRYONIC STEM CELLS 
 
 
A Thesis 
Presented to the 
Faculty of 
California State University, 
San Bernardino 
 
 
by 
Joseph Valenzuela Madrid 
December 2018 
Approved by: 
Dr. Nicole Bournias, Committee Chair, Biology 
Dr. Nicole zur Nieden, Committee Member, UCR, Biology 
Dr. Jeffrey Thompson, Committee Member 
 
 
 
 
 
 
 
 
 
 
© 2018 Joseph Valenzuela Madrid  
 
 
 
iii 
 
ABSTRACT 
Though it is well known that tobacco related products can cause prenatal 
maldevelopment, very little is known on how tobacco products affect bone tissue 
as it develops in the embryo. Identifying which chemicals can induce the greatest 
harm to the prenatal skeletal system is an improbable task as there are over 
7,000 chemicals in tobacco smoke alone. We hypothesized that the Toxicological 
Priority Index (ToxPI) program can be used to rank osteogenic cytotoxicity 
potential to aid in the assessment of what chemicals out of the thousands can 
cause osteogenic differentiation inhibition. ToxPI aggregates information from 
various assays and incorporates them into visual “pie charts” which allow 
chemicals to be ranked against each other by given parameters. The larger the 
pie chart the greater likelihood of potential effects and vice versa. Seventeen 
tobacco chemical constituents were ranked using ToxPI and those chemicals 
with pie charts (0<X) are predicted to have decreased cell viability and 
differentiation capabilities where chemicals with null pie charts (x=0) will not have 
any effects.  
 To assess the ability of ToxPI to correctly predict maldevelopment in silico 
eight compounds were then tested in vitro: four of them being ToxPi positive and 
the other four having null predicted effects. To verify the predictions, human 
embryonic stem cells were differentiated into osteoblasts and exposed to various 
concentrations of each compound. Cell viability was measured via MTT assay in 
conjunction with a calcium assay to measure osteogenic differentiation. In 
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addition, adult human feeder fibroblasts cell viability in response to exposure was 
measured. ToxPI positive predictions (x<0) all exhibited decreased cell viability 
though in various order. All tested ToxPI null charts produced no change in cell 
viability. However, one of the ToxPI null chemicals, nicotine, although not 
cytotoxic in vitro, caused differentiation inhibition. Together our data suggests 
that ToxPi might be useful to identify strongly inhibitory chemicals based on their 
cytotoxicity but might also give false negative results for chemicals that cause 
differentiation inhibition at sub-toxic levels. 
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CHAPTER ONE 
INTRODUCTION 
 
Health Consequences of Exposure to Tobacco 
The environment plays a prominent role in human health as it could 
negatively impact all stages of life. The World Health Organization (WHO) 
estimates 24% of the global disease burden and 23% of all deaths to be 
attributed to environmental factors.1 Environmental factors can come in the 
means of biological, chemical, and radioactive substances. For instance, 
continuous use of medications such as valproate have been associated with 
short stature2, and supplemental addition of retinoic acid in the diet of a pregnant 
mother has been linked to craniofacial abnormalities.3 With the potential to alter 
and harm human health it is of great importance to study and assess a 
chemical’s range of potential outcomes in the absence of an acquired disease or 
genetic predisposition.  
The most common environmental and indoor toxicant is exposure to 
smoke via cigarettes. Such exposure can be through mainstream smoke (MS) 
that is actively inhaled by the user, side stream smoke (SS), which burns off the 
ends of cigarettes, and third hand smoke (THS) that consists of left-over 
particulate matter that can rest in clothing, carpets, and any outdoor or indoor 
surfaces. In addition, exposure can happen orally through use of noncombustible 
tobacco products such as chewing tobacco. All these tobacco products are 
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known to cause a broad spectrum of health effects. In adults, its use is 
associated with an increased risk of gum disease, blindness, reduced fertility in 
addition to respiratory complications and cardiovascular disease. Smoking is 
strongly associated with cancers that are not limited to the head, neck, lung, 
bladder, stomach, and colon.4 Tobacco products overall will reduce human 
health: if every smoker decided to stop smoking, one in three cancer deaths 
would cease to exist.3 The Center for Disease Control (CDC) estimates that one 
in five deaths in the United States can be attributed to cigarette smoking and is 
responsible for 480,000 deaths annually.4 In addition to disease, the total 
economic cost of smoking is 300 billion dollars a year in the United States alone.5 
Exposure to tobacco products can also induce tissue specific effects as seen in 
adult bone. Smoking has been shown to disrupt osteogenesis and can lead to 
osteoporosis, an increase in bone fragility, and an overall delay in bone healing.6  
Despite these known health consequences of tobacco use, 10-20% of 
pregnant women report smoking during their first trimester of pregnancy.7 
Smoking during pregnancy is linked to premature birth, sudden infant death 
syndrome, low birth weight, and ectopic pregnancy4, but whether tobacco 
exposure is harmful to the developing skeleton is understudied. However, 
perpetrating bone growth and density could have irreversible effects on the 
development of the fetus and pose a significant threat to the baby’s health 
postpartum as evidence suggests skeletal growth is programmed very early in 
development. In fact, a few years ago, Rasmussen reported that while tobacco 
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exposure may not lead to premature death, it can still perturb development to 
cause a birth defect.8   
 
Skeletal Development 
The skeleton protects critical organs such as the brain in addition to 
providing a scaffold, which the body rests upon.  The axial skeleton provides the 
core of the skeletal system and consists of the spinal column, and ribcage. The 
appendicular skeleton encompasses the extremities of the skeletal system, but 
also include the pelvic and pectoral girdle along with the clavicles. Skeletal 
development post fertilization starts from anterior to posterior, essentially starting 
from the skull descending to the spinal column while filling out the rib cage. The 
extremities of the body develop from the pelvic and pectoral girdles and extend 
out laterally.9 Two bone development processes are responsible for formation of 
the skeleton: intramembranous and endochondral ossification. Neural crest 
derived mesenchymal precursors undergo intramembranous ossification, which 
is a direct bone formation process.  Parts of the skull and clavicles develop bone 
through intramembranous ossification. Cells from a mesoderm mesenchymal 
origin use endochondral ossification that uses a temporary cartilage placeholder 
that is eventually replaced with bone, as seen in many long bones. The 
appendicular skeleton and base of the skull is primarily produced via this type of 
ossification.10 Once developed, osteoblasts, the bone forming cells, and 
osteoclasts, which resorp the bone matrix, are the predominant cell types in bone 
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and their interaction drives bone remodeling. The skeleton is continuously 
restructured and grows in both diameter and length post birth continuing into 
adolescence.11 
 
Developmental Biology 
Developmental biology studies the initiation and construction of the 
organism as a developing embryo.  This is contrary to other fields of biology that 
focus on maintenance and repair of adult organisms. Studying embryonic 
development can help shed light on the process of how organisms differentiate, 
organize, and grow before birth. This transient stage between egg and sperm 
into a functioning organism is critical as this developmental period is relatively 
quick and short. During this limited time frame a major question of how 
environmental cues impact the developmental process needs to be assessed.  
Most mammal keep their embryos inside of themselves and exposure to 
environmental agents through the mother will impact the development of the 
embryo as well. This is a major concern as the use of chemicals has increased in 
various sectors of transport, agriculture, and industry. WHO estimates that 
47,000 deaths annually can be directly attributed to chemical exposure. In the 
absence of fatal exposure, teratogens are of great concern. Teratogens are 
agents that can disturb development of the embryo and produce a birth defect. 
This is especially alarming as the number of birth defects have been increasing 
in the United States by 150,000 a year.12 These defects have ranged from limb 
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reduction, cardiac malformation and impaired neural development. In summary, 
the study of development is necessary, as it adds depth to other biological 
disciplines such as cell biology, anatomy, and genetics.  
 
Embryonic Stem Cells 
Embryonic stem cells (ESCs) are unspecialized pluripotent cells, that give 
rise to all specialized cells within the body (Figure 1). This pluripotency allows 
ESCs to differentiate into the three germ layers (endoderm, mesoderm, 
ectoderm), which encompass over 200 cell types.13 However, ESCs do not give 
rise to extraembryonic tissues, such as the placenta, and can only develop the 
embryo proper. Derived from the inner cell mass of the blastocyst at day 5 post 
fertilization, ESCs can be isolated and plated to grow in laboratory conditions. In 
culture, ESCs self-renew and replicate themselves into the same non-specialized 
cell continuously for long periods of time, a state that is maintained by the 
presence of a triad of transcription factors composed of OCT4, SOX2, and 
NANOG, which co-occupy regions of ESC chromatin to activate pluripotency 
genes and repress differentiation genes.14,15 
With the suppression of pluripotency markers, it is possible for ESCs to 
begin to differentiate into other cell types. In a non-adherent environment, ESCs 
can be forced to aggregate and form embryoid bodies, which contain 
differentiating cells of all three germ layers. The aggregation of ESCs in 
suspension is commonly referred to as the hanging drop method. When plated 
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on an adherent surface, embryoid bodies spontaneously differentiate into a 
variety of cell types, one of the most prominent being cardiomyocytes that can 
contract with synchronistic rhythmic activity.16 To help drive ESCs to other cell 
lineages and fates chemicals can be supplemented in culture.  
The potential use of ESC is a remarkable tool that allows predictability 
through in vitro results. Murine ESC have been harvested and used since 1981 
but it was not until the late 1990s that the first human stem cells were isolated. 
Adult stem cells differ from ESC as their differentiation potential to 
produce the germ layers of the body is limited and reduced to certain organs or 
tissues due to the pluripotency transcription triad being altered or absent.  Due to 
this limited differentiation potentially, adult stem cells are considered multi- or uni- 
potent. In addition to a reduced amount of lineage potential, adult stem cells do 
not have unlimited proliferative potential and do have a finite limit to replace cells. 
With the limited ability to create certain cell types adult stem cells are only able to 
differentiate and replace those tissues from where they are found. So far adult 
stem cells have been found in mesenchymal, hematopoietic, and neural 
tissues.17 
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Figure 1. Pluripotency of Embryonic Stem Cells. ESCs can differentiate to all 3 germs layers. 
Several key transcription factors control stem cell pluripotency and renewal. With the suppression 
of pluripotency markers and supplementation of chemical factors ESC can be pushed to a certain 
cell lineage in vitro. Embryonic Stem Cell [Pluripotent: Embryonic stem cells are able to develop 
into any type of cell, excepting those of the placenta. Only embryonic stem cells of the morula are 
totipotent: able to develop into any type of cell, including those of the placenta.]. (n.d.). Retrieved 
December 22, 2017, from https://en.wikipedia.org/wiki/Embryonic_stem_cell 
 
 
Embryonic Stem Cell Test 
To limit human exposure risk to hazardous environmental chemicals and 
drugs, chemical compounds have been historically screened in rodents. 
However, since the mid-20th century there has been a push to reduce the 
amount of animal use and suffering for scientific purposes. The concept of the 
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Three R’s (Replacement, Reduction, and Refinement) outlined the importance of 
refraining from animal use and when possible use in vitro and projection models 
to perform experiments.18,19 A cellular approach allows safe, reliable, and high 
throughput results. Three such approaches based on cells, the micromass whole 
cell culture assay, the FETAX test (Frog Embryo Teratogenesis Assay-Xenopus), 
and the Embryonic Stem Cell Test (EST)20 were validated in 2002 by the 
European Centre for Validation of Alternative Methods (ECVAM) for accuracy 
and predictivity. While all three were found potentially useful, only the EST 
avoided the use of animal testing entirely. In addition to avoiding the sacrificial 
use of animals, the EST is less laborious than other in vitro techniques and 
requires less technical skill.  
To classify potentially embryotoxic compounds the EST uses three 
endpoints: i) Viability of 3T3 adult cells ii) viability of ESCs iii) differentiation 
capability of ESCs to cardiomyocytes. ESCs are a good model for development 
as gene expression during spontaneous differentiation into cardiomyocytes in 
vitro mimics development in utero. Cell viability of cardiomyocytes is measured 
via the MTT indirectly through metabolic activity, whereas differentiation is 
determined by the amount of beating clusters using microscopy. Dose response 
curves are developed, and half maximal activity is recorded for cytotoxicity (IC50) 
and differentiation inhibition of cardiomyocytes (ID50). These results are then 
incorporated into a bio-statistical model, where compounds and chemicals can 
be classified into three categories based on their ability to induce developmental 
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toxicity: Strongly embryotoxic, weakly embryotoxic, and non-embryotoxic.21,22 
Validation studies on the EST to classify embryo-toxins compared in vitro to in 
vivo data and found the EST had a 78% correct classification for the tested 
compounds. 
Improvement to the EST 
The classical EST used cardiomyocytes as their differentiation capabilities 
were spontaneously generated in vitro, though some exogenous factors can 
have effects on specific tissues such as the central nervous system and leave 
other organ and tissues unharmed.23 To expand the usefulness of the EST, 
protocols to differentiate ESCs into a variety of tissues including neural, adipose, 
and bone, were then subsequently developed.24,25  
The zur Nieden lab has been instrumental in developing differentiation 
protocols to drive cell commitment of human and murine embryonic stem cells 
into chondrocytes and osteoblasts.24-26 To initiate differentiation, murine ESCs 
are switched to culture conditions from which pluripotency factors are omitted. 
Subsequent supplementation with the osteogenic specific factors 1,25(OH)2 
vitamin D3, β-glycerophosphate and ascorbic acid sends the cells down an 
osteogenic path, during which the cells express a variety of bone markers in 
sequence mimicking embryonic bone development. The final phenotypic 
appearance of osteoblasts in culture is characterized by black appearing 
deposits, which are made up of calcium.27 
To improve the EST, additional technical endpoints were added such as 
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RT-PCR and flow cytometry to concentrate on genes necessary for differentiation 
into a specific cell lineage and standardize read-out.28 Another added benefit of 
such techniques is that monitoring gene and protein expression can assess real 
time regulation and provide temporal data specific for each chemical. 
More recent alterations to the classical EST included the animal model 
used in the experiment. The classical EST uses murine ESCs, though the use of 
primate stem cells could abrogate the differences between species that have 
been reported in toxicological studies. Zur Nieden and colleagues have provided 
evidence that primate and human cells used in the EST are more sensitive to 
certain compounds than their murine counterparts.29 In addition, the murine to 
human switch also provides an additional advantage as human cells do not 
require embryoid bodies to form during the experimental process. Human ESCs 
can be grown and plated directly into culture plates, which allows less intrusion 
during the experiment and eliminate the technically and laborious task of 
performing the hanging drop method. Additionally, mature cell line used in the 
EST was switched from mouse 3T3 cells to human foreskin fibroblasts (hFFs) to 
better mimic the mother’s toxicological response during pregnancy.  
 
Toxicology Priority Index 
 
To prioritize chemicals for toxicity testing the Environmental Protection 
Agency (EPA) in conjunction with the University of South Carolina at Chapel Hill 
developed the Toxicology Priority Index (ToxPI) Graphical User Interface using 
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data from aggregated database sources such as the EPA’s Tox21 and Toxcast. 
The ToxPI system is a free downloadable prioritization support tool that can 
evaluate the toxicity of a given chemical based on various sources of data and 
can incorporate various data parameters that it integrates into a simple visual 
representation in the form of a pie.30 The data compiled from various sources 
such as in vitro assays are assimilated at the discretion of the user based on 
preset and post modification settings in the ToxPI GUI.31 Each pie chart 
produced by ToxPI is a depiction of one specific chemical, whereas the slices 
that make up the pie chart are components or attributes of a chemical such as 
chemical properties, biological pathways, and exposure data (Figure 2). These 
slices in turn can be made of multiple smaller slices, which are representatives of 
each assay or endpoint that is used. Each slice of the pie chart for each chemical 
can also be given higher priority over other assays by giving more “weight” to a 
specific assay and less weight to a non-specific assay thus effecting the size of 
the pie charts.  
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Figure 2. ToxPI Visualization Chart. ToxPI can incorporate data based off a variety of chemical’s 
properties, bioactivity, and in vitro assay data. The various data parameters can then be 
compared to one another and displayed as a visual pie chart. Those chemicals with the larger pie 
charts have the highest predicted effects whereas the chemicals with smaller pie charts have a 
smaller predicted effect. Bioinformatics. 2013 Feb 1; 29(3): 402–403. Published online 2012 Nov 
29. doi: 10.1093/bioinformatics/bts686 
 
 
Scaling can also be applied for each slice of a pie chart. In vitro data in the 
ToxPI is given in micromolar concentration and scaling the data in 
log10(x)+log10(max(x)) allows lower micromolar concentrations to result in larger 
pie charts while higher micromolar concentrations producing smaller pie charts.31 
ToxPI scaling is versatile and includes binary, zero to one “hit” and “non-hit” 
systems, and linear scaling that allows smaller numbers to result in reduced pie 
charts and larger numbers to result in greater pie charts. Scaling each slice 
specifically for its data allows different slices to be compared to one another 
despite each slice of a chemical’s pie chart representing different aspects its 
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attributes.  
The outcome of setting these different pathways not only produces a pie 
chart visualization but takes in all information about a specific chemical and 
reduces it to a unit-less number. In other words, each slice is ranked on a 
dimensionless number system ranging from 0 to 1. A non-effective chemical slice 
would have the least effect (0) and those with the highest predicted effects would 
be given a 1. The total sum of every slice produces the overall ToxPI score. If a 
chemical in ToxPI is composed of five slices those with the greatest effects would 
not only be the biggest pie chart but would have the highest score (5) whereas 
the lowest number would be 0 and the pie chart would be unfilled.   
14 
 
 
Figure 3. Window Preview of ToxPI Data. Chemicals properties are divided by an individual color 
and is turn made up of multiple smaller slices. For each color, appropriate scaling is applied for 
every data set and conference intervals are calculated.  Missing data % is shown in the middle of 
each ToxPI and an overall ToxPI score is generated. Environ Health Perspect. 2010 Dec; 
118(12): 1714–1720.Published online 2010 Sep 8. doi: 10.1289/ehp.1002180 
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The ToxPI GUI produces a short summary for each of the calculated 
chemicals. It gives vital information on the ToxPI score, its value broken up into 
specific slices, how many chemicals are being ranked against each other and the 
missing data in value percent. This value percent is also seen in the middle of 
each ToxPI slice (Figure 3). Those with more grey or dark shades in the middle 
of their ToxPI calculations have missing data. All chemicals are also visualized 
on the same ToxPI plane and are given in a standard X, Y graph (not shown). In 
this format, the standard deviations are shown between the chemicals and how 
these could affect the chemicals rank. Y values represent the chemical ranks 
whereas the X value represent the calculated ToxPI scores for each of the 
chemicals.  
 
The Interactive Chemical Safety and Sustainability Database 
Data for the ToxPI software can be mined using the Aggregated 
Computational Toxicology Online Resource (ACToR) database and can be easily 
exported using the interactive Chemical Safety and Sustainability (iCCS) tab. The 
interactive iCCS dashboard contains data from multiple database sources 
including Toxicity Forecaster (Toxcast) and Toxicity Testing in the 21st century 
(Tox21); the latter has been assimilating data since 2007. The iCCS houses data 
on just over 9,076 chemicals and just under 1,200 assays. The data can be 
filtered by different parameters such as a specific time points, specialized 
tissues, cell type, and gene expression.  
16 
 
Other information on bioactivity of chemicals are also available such as 
human oral absorption and LogP values. The iCCS database assays are all 
given in activity call (AC50) values, which are a superset of the classical known 
50% inhibition of cytotoxicity and 50% inhibition of differentiation values. AC50 
values are indicative of either inhibitory or activation effects. After filtering through 
selected parameters at the discretion of the user the iCCS data can then be 
exported via a downloadable excel workbook. The excel file then can be 
reformatted to fit the ToxPI system and integrated into a matrix that can be 
uploaded into the ToxPI program itself. ToxPI analysis has been useful in 
assessing the ability of novel chemicals to disrupt endocrine receptors32, vascular 
development and remodeling33, and evaluate risk associated with obesity and 
diabetes.34  
 
Aims and Objectives 
Previous data from the zur Nieden lab (see chapter 3) points to an 
inhibition of osteogenesis caused by various tobacco products. However, overall, 
it is challenging to decipher how an individual chemical in tobacco smoke 
contributes to toxicity or teratogenic effects during embryogenesis. A major 
obstacle in studying these effects is the tobacco smoke itself, a concoction 
composed of more than 7,000 chemical constituents.  With the passage of the 
Family Smoking and Prevention Act the Food and Drug Administration (FDA) in 
2009 released a list of harmful and potentially harmful constituents (HPHCs) in 
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tobacco products and tobacco smoke.36 While most of the chemical constituents 
in tobacco smoke and products remain incompletely identified, the HPHC may 
provide a good framework for focusing on those chemicals that pose the greatest 
threat to human health. While the HPHC list has substantially reduced the 
number of chemicals to test down to 97, testing these chemical constituents 
individually or in assortments would be a time consuming and expensive venture. 
Therefore, the specific objectives of this study will address the following two 
specific aims. 
 
Specific Aim 1: Use ToxPI as a prioritization tool to rank and predict chemical 
constituents   in tobacco products that can have cytotoxic and teratogenic effect 
on skeletal development. 
Specific Aim 2:  Determine the toxicity of the highest predicted chemicals through 
a well-established in vitro osteogenic protocol using human ESCs.  
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CHAPTER TWO 
MATERIALS AND METHODS 
 
Materials 
1. mTESRTM 1 (Stem Cell Technologies, cat. no. 85850). mTESR medium was 
sold as a kit that included basal medium and supplements. The medium was 
completed when the supplements were added to the basal medium. Stored 
at 2-8 °C. 
2. DMEM with 4500 mg D-Glucose/L (Stem Cell Technologies, cat. no. 36250). 
Stored at 2-8 °C. 
3. Dulbecco’s Modified Eagle’s Medium and Ham’s F-12 Nutrient Mixture 
(DMEM/F12) (ThermoFisher, cat. no. 11320-033). Stored at 2-8 °C. 
4. 1X Phosphate Buffered Saline (PBS) without calcium, magnesium, or phenol 
red, sterile, pH 7.4 (ThermoFisher, cat. no. 10010-023). Stored at 2-8 °C. 
5. Human embryonic stem cells (hESC), (e.g. H9 line from WiCell Research 
Institute). 
6. Human foreskin fibroblasts (hFF) (ATCC, cat. no. CRL-2429™). 
7. 2% gelatin, sterile cell culture grade (Sigma Aldrich, cat. no. G1393) Working 
0.1% Gelatin: 2 mL of a 2% gelatin stock solution to 38 mL of pre-autoclaved 
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sterile water. 0.1% gelatin was filtered using a 0.1 µm filter and stored at 2-
8°C. 
8. Dimethyl Sulfoxide (DMSO) (Sigma, cat. no. 472301). Stored at room 
temperature.  
9. Matrigel Matrix hESC (Stem Cell Technologies, cat. no. 354277). The 5 mL 
vial of Matrigel matrix was thawed overnight at 2-8°C. Thawed matrigel 
matrix was diluted 1:1 with 5 mL of cold DMEM/F12, and completely mixed, 
and placed in 1 mL aliquots into 15 mL conical tubes. These aliquots were 
stored at -20°C until needed. Working Matrigel: 1 mL of 1:1 diluted Matrigel 
Matrix aliquot was thawed at 2-8°C and 14 mL of cold DMEM/F12 was 
added. Working Matrigel can be stored at 2-8°C  
10. Accutase, pre-made in Dulbecco's phosphate-buffered saline (DPBS) without 
Ca2+ and Mg2+ (Innovative Cell Technologies, cat. no. AT-104). Stored at 2-8 
°C. 
11. Batch-tested fetal bovine serum (FBS). Stored at -20°C. 
12. 100X MEM Non-Essential Amino Acid (NEAA) solution (Sigma, cat. no. 
RNBD8621). Stored at 2-8 °C. 
13. 10,000 U/mL Pencillin/Streptomycin (Lonza, cat. no. 17-602E). Stored at 2-8 
°C. 
14. 2-Mercaptoethanol (β-ME) (Gibco, cat. no. 21985). Stored at 2-8 °C. 
15. Beta-Glycerophosphate (BGP) (Sigma, cat. no. 65422). A 1 M stock was 
prepared by adding 10.802 grams into 50 mL of PBS and stored at -20°C.  
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16. 1-α, 25-(OH)2 vitamin D3 (Vitamin D3) (Sigma Aldrich, cat. no. 17936). A 
stock of 50 mg/mL by adding 2.5 grams into 50 mL of PBS and stored at -
20°C. 
17. Ascorbic Acid (AA). (Sigma Aldrich cat. no. A4403). A stock concentration of 
50 mg/mL was by adding 2.5 grams into 50 mL of PBS and stored at -20°C. 
18. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
(Amresco, cat.  no. 0982C140). A stock of 5 mg/mL MTT in 1X PBS was 
prepared. The stock was sterile filtered using a 0.1 µm filter and stored at -
20°C.  
19. Sodium Dodecyl Sulfate (SDS) (Sigma Aldrich, cat. no. 436143). 20% SDS 
solution can be made by adding 20 mL of SDS and 80 mL of PBS. Stored at 
room temperature.  
20. Isopropanol (Sigma Aldrich, cat. no. I9516). Stored at room temperature. 
21. MTT Desorb: prepare MTT desorb solution containing 3.5% of 20% SDS and 
96.5% isopropanol. Stored at room temperature.  
22. NP-40 (abcam, cat. no. ab142227) 
23. Sodium Deoxycholate (Sigma Aldrich, cat. no. D6750) 
24. Radioimmunoprecipitation (RIPA) buffer. 1X PBS containing 0.1% SDS, 1% 
25. NP-40 and 0.5% sodium deoxycholate. pH needs to be set to 7.2. Stored 
at 2-8°C 
25. Ca2+ reagent: 0.15 mM Arsenazo III (2,2’-bisbenzene-arsonic acid, DCL 
Toronto). Ready-to-use reagent. Stored away from light at room 
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temperature. 
26. Calcium Carbonate (Fisher Scientific, cat. no. C63-10). A calcium stock 
solution of 10 mg/mL in PBS was prepared and stored at 2-8°C. 
27. Bovine Serum Albumin (BSA). Store powder at 2-8°C. A stock solution of 50 
mg/mL in PBS was prepared and stored at 2-8 °C. 
28. DC Protein Reagent Kit (Biorad, cat. no. 500-0111). When ready to use 
1000µL of Reagent A was mixed with 25µL of Reagent S to make a new 
solution A’. Stored away from light at room temperature.  
29. 6-well non-treated cell culture plates (NEST Biotechnology, cat no. 703011). 
30. 48-well non-treated cell culture plates (Cell Star, cat. no. 677102) 
31. Absorbent underpads with waterproof moisture barrier (VWR, cat. no. 82020-
845) to be used as blotting paper. 
32. Flat 96-well microtiter assay plates (e.g. Corning Costar). 
33. Heidolph Polymax Wave Shaker (Brinkmann). 
34. Refrigerated microcentrifuge, e.g. Eppendorf 5415R and 1.5 mL 
microcentrifuge tubes (VWR, cat. no. 87004-262). 
35. ELISA plate reader with filter sets for 550-570, 650 and 750 nm, e.g. Tecan 
Safire 2™.  
Media 
1. mTESRTM 1. Stored at 2-8°C. 
2. hFF medium: DMEM, 10% FBS, 1% NEAA and 0.5% of 
Pencillin/Streptomycin. Stored at 2-8°C. 
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3. Control Differentiation Media (CDM): DMEM, 10% (FBS), 1% NEAA, 0.5% of 
Pencillin/Streptomycin and 0.1 mM β-ME. Stored at 2-8°C. 
4. Osteogenic Differentiation Media (ODM): CDM media supplemented with 10 
mM BGP, 50 mg/mL AA, and 50 mg/mL of Vitamin D3. Stored at 2-8°C. 
Chemicals 
1. Nicotine (Toronto Research, cat. no. sc-N0267). Nicotine’s stock 
concentration was made by diluting 5mg in 1mL of DMEM (5,000 µg/mL). 
The stock concentration was filtered using 0.1 µm filters and stored at -20°C.  
2. Coumarin (Santa Cruz, cat. no. sc-205637). Coumarin’s stock concentrations 
was made by diluting 50mg in 1mL of DMSO (50,000 µg/mL). The stock 
concentration was stored at -20°C. 
3. Catechol (Santa Cruz, cat. no. sc-215763). Catechol’s stock concentration 
was made by diluting 50mg in 1mL of water (50,000 µg/mL). The stock 
concentration was filtered using 0.1 µm filters and stored at -20°C. 
4. Cotinine (Toronto Research, cat. no. C725000) Cotinine’s stock 
concentration was made by diluting 5mg in 1.5mL of DMEM (1,292 µg/mL). 
The stock concentration was filtered using 0.1 µm filters and stored at -20°C. 
5. Benz(a)anthracene (BAA) (Santa Cruz, cat. no. sc-252409). BAA’s stock 
concentrations was made by diluting 50mg in 1mL of DMEM (50,000 µg/mL). 
The stock concentration was stored at -20°C. 
6. Nicotelline (Toronto Research, cat. no. N401200). Nicotelline’s stock 
concentration was made by diluting 5mg in 5mL of DMEM (5,000 µg/mL). 
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The stock concentration was subsequently filtered using 0.1 µm filters and 
stored at -20°C. 
7. Urethane (Sigma Aldrich, cat. no. U2500). Urethane’s stock concentration 
was made by diluting 2,000mg in 6mL of DMEM (333,286 µg/mL). The stock 
concentration was filtered using 0.1 µm filters and stored at -20°C. 
8. Quinoline (Sigma Aldrich, cat. no. 241571). Quinoline was stored at -20°C. 
9. Acrylamide (Sigma Aldrich, cat. no. 23701). Acrylamide was stored at -20°C. 
10. N-formylnornicotine (NFN) (Toronto Research, cat. no. F700875). NFN’s 
stock concentration was made by diluting 10mg in 1.5mL of DMEM (6,666 
µg/mL). The stock concentration was filtered using 0.1 µm filters and stored 
at -20°C. 
11. 4-(N-Methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK) (Toronto 
Research Chemicals, cat. no. M325750). NNK’s stock concentration was 
made by diluting 10mg in 1mL of DMEM (10,000 µg/mL). The stock 
concentration was filtered using 0.1 µm filters and stored at -20°C. 
12. 4-(methylnitrosamino)-4-(3-pyridyl) butanal (NNA) (Toronto Research, cat. 
no. M325650). NNA’s stock concentration was made by diluting 10mg in 
1mL of DMEM (10,000 µg/mL). The stock concentration was filtered using 
0.1 µm filters and stored at -20°C. 
13. (R,S)-N-Nitrosoanatabine (NAT) (Toronto Research, cat. no. N524750). 
NAT’s stock concentration was made by diluting 5mg in 1.5mL of DMEM 
(3,330 µg/mL). The stock concentration was filtered using 0.1 µm filters and 
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stored at -20°C. 
Websites 
ToxPI program was downloaded at http://comptox.unc.edu/toxpi.php. All 
data was found at https://actor.epa.gov/actor/home.xhtml on the Toxicity 
Forecaster (ToxCast) Dashboard link. 
 
Methods 
Toxicity Forecaster Data Mining 
The Environmental Protection Agency’s Aggregated Computational 
Toxicology online resource (ACToR) was accessed at 
https://actor.epa.gov/actor/home.xhtml on September 20, 2017. The Toxicity 
Forecaster (ToxCast) Dashboard link was selected and a new window 
appeared.  The chosen 17 chemicals were individually inserted into the chemical 
name search bar. Chemicals were selected with the advanced search bar that 
prompted an additional window to appear. Under “Filter assay using” biological 
processes target was selected from the drop-down menu. From the on-value 
section five biological processes were selected from drop-down menu: Cell 
Death, Cell Proliferation, Cell Morphology, Oxidative Phosphorylation, and 
Mitochondrial Depolarization. Selected chemical’s information was viewable 
under the chemical and assays tabs and downloaded using the Export tab at the 
top right corner of the browser. For each chemical the entire process was 
repeated with a new window browser. All downloaded data was reformatted into 
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a single excel csv. file for compatibility with the ToxPI GUI. The reformatted data 
is shown below.  
 
 
Table 1. Excel File Uploaded in ToxPI. 
 
 
 
ToxPI Pie Chart Generation 
The ToxPI GUI was downloaded at http://comptox.unc.edu/toxpi.php and 
saved as a java application on the desktop. Data exported from the Toxicity 
Forecaster was reformatted in an excel sheet and inserted into the ToxPI 
program (download and format instructions above). The ToxPI GUI was opened 
and the reformatted excel sheet was uploaded by the insert tab. In total, 
seventeen chemicals were chosen manually and the generate charts icon was 
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selected which allowed each of the biological processes to be sorted. The data 
was sorted by the assays option and each assay option was named for each 
biological process. For each assay option a corresponding data selection icon 
appeared and data for each biological process was selected manually. Each 
biological process was given its own unique color using the color bar; Cell 
Morphology 2 assays (Green), Mitochondrial Depolarization 5 assays (Purple), 
Oxidative Phosphorylation 8 assays (Yellow), Cell Death 27 assays (Black), and 
Cell Proliferation 30 assays (Red).The 5 biological processes pie slices were 
given scaling via scaling option by selecting -log10(x)+log10(max(x)) on the drop-
down menu, this would ensure that lower active AC50 values were given 
separation from non-active hits. Pie charts were generated by selecting final 
generation tab and individualized pie charts were displayed on the screen. Pie 
charts for all 17 chemicals were saved by selecting save images option. The 
ToxPI images were saved individually and together.   
Cell Passaging and Maintenance 
hFF Culture Maintenance. hFFs were obtained from ATCC and were 
grown in 0.1% gelatin pre-coated 6-well plates and kept at 37°C in a controlled 
humidified 5% CO2 incubator. 6-well plates were pre-treated with 0.1% gelatin for 
15 minutes before the start of passaging and subsequently removed. While in 
culture hFFs were routinely checked for bacterial, yeast, and microbial 
contamination using an inverted microscope. Cultures were also checked via the 
inverted microscope for confluency. Cultures were considered confluent when 
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hFFs covered 70% of the surface area of an individual 6-well and were passaged 
in a 1:6 ratio. When a 6-well culture reached confluency hFF media was removed 
and washed with PBS. PBS was subsequently removed and treated with 1mL of 
Accutase. When hFFs dissociated and were suspended in solution, 1mL of hFF 
media was added and consequently put in a 15mL conical tube and spun down 
in a microcentrifuge. The supernatant was removed, and the left-over pellet was 
resuspended in 6mL of hFF media. Each well of a 6-well plate was given 1mL of 
the resuspended hFF cell suspension. hFFs were passaged every two to four 
days when cells reached 70% confluency.  
Human Embryonic Stem Cell Culture Maintenance. H9 hESCs were 
obtained from WiCell. All human pluripotent cells were maintained in mTESR 
media in pre-treated matrigel coated 6-well plates. 6-well plates were coated with 
matrigel for 20-30 minutes and subsequently removed prior to the start of 
passaging. hESCs were grown in an incubator at 37°C in a controlled 5% CO2 
humidified incubator. While in culture cells were routinely checked for bacterial, 
yeast, and microbial contamination using an inverted microscope. Cell 
morphology was also assessed during this time to ensure pluripotency of the H9 
cells. Cells that began to differentiate (fissured morphology) were discarded and 
new H9s were used. 6-well cultures were assessed for confluency with an 
inverted microscope and passaged when colonies covered 70% of the surface 
area of an individual 6-well plate. Cells were also passaged when colonies grew 
close to each other but were not touching. Cultures that reached confluency were 
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passaged in a 1:6 ratio. Confluent culture’s mTESR media was removed and 
washed with PBS. The PBS was removed, and cells were treated with 1mL of 
Accutase. When colonies dissociated and were suspended in Accutase, 1mL of 
mTESR was added and consequently put in a 15mL conical tube and spun down 
in a microcentrifuge. The supernatant was removed and resuspended in 6mL of 
mTESR. Each well of a 6-well plate was given 1mL of the resuspended cells in 
mTESR. hESCs were passaged every two to four days as needed.  
Cell Counting and Seeding. Seeding density was calculated from a 6-well 
plate to a 48-well plate for the MTT and calcium endpoints. The surface area 
ratio was calculated by dividing the area of 6-well plate over the surface area of a 
48-well plate. The surface area ratio was multiplied by the passage ratio 1:6 to 
obtain the dilution factor. The resuspended cell volume was divided over the 
dilution factor and multiplied by 1000 to obtain the appropriate amount of cell 
suspension needed per well of a 48-well plate. The cell suspension needed per 
an individual 48-well was multiplied by the number of wells needed for the total 
cell suspension. The total volume of media was calculated by the amount of 
media (300µL) per individual 48-well multiplied by the number of wells. The total 
cell suspension and total volume of media were mixed and 300µL was added to 
each 48-well plate.  
Osteogenic Differentiation and Endpoints 
H9 hESCs were seeded into 48-well plates from a 6-well plate (Cell 
counting and seeding instructions above). Cells were grown to 70% confluency 
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and checked daily using the inverted microscope. When cells reached 70% 
confluency or when colonies grew close to one another without touching the 
differentiation protocol was started. mTESR medium was removed from each of 
the wells and replaced with CDM. hESCs were given CDM until Day 5 where the 
media was removed and replaced with ODM. Cells continued to grow in ODM 
until Day 20. Media was replaced every 2-3 days during the differentiation 
experiment.  
          Dilution Series. Cells from Day 0 to Day 20 were fed with a specific starting 
concentration for each chemical, starting from the stock, each concentration was 
made by subsequent serial dilutions (all chemicals tested were in a 10-fold 
dilution series).  
MTT Assay (Cell Viability). To determine cell viability hESCs and hFFs 
were seeded (Cell counting and seeding instructions above) in separate 48-well 
plates with 5 replicates for each test chemical concentration. hESCs were 
differentiated into osteoblasts using our labs osteogenic protocol while hFFs 
were fed hFF media during the entirety of the experiment. On day 20 cells were 
supplemented with 50µL of PBS dissolved MTT for each well containing 300µL of 
medium and placed inside an incubator for 2 hours in 5% CO2 atmosphere at 
37°C under sterile conditions. After the 2-hour incubation period the 48-well 
plates were placed upside down on blotting paper where the media was 
absorbed and discarded. 325µL of MTT Desorb was added to each of the 48-
wells and placed on a micro-shaker for 15 minutes. 100µL of each well with MTT 
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desorb was pipetted into a 96-well plate and the absorbance was read at 570nm 
with a Bio-rad iMarkTM   microplate reader. The percent cell viability was 
calculated by normalizing treated wells with non-treated control wells. 
Lowry Assay (Protein Determination). To determine protein content, 
hESCs were seeded (Cell counting and seeding instructions above) in a 48-well 
plate with 5 replicates for each test chemical concentration and differentiated into 
osteoblasts using our labs osteogenic protocol. Upon collection (Day 20) CDM 
media was removed and hESCs were washed with PBS. After the removal of 
PBS, 300µL of RIPA buffer was added to each well and scrapped using a pipet 
tip to dislodge the calcium from the base of the culture vessel. The scrapped 
RIPA lysates were collected and placed into Eppendorf tubes. Protein standards 
were prepared from the BSA stock solution in a 7 concentration serial dilution 
series that ranged from 0.0 mg/mL – 1.5 mg/mL.  5µL of each BSA standard 
concentration and RIPA collected lysates were placed into a 96-well plate. 
Approximately 25µL of Reagent A’ was combined with RIPA lysates and BSA 
concentrations and 200µL of Reagent B was subsequently added. The 96-well 
plate was incubated for 15 minutes on a micro-shaker and absorbance was read 
at 750nm on a Bio-rad iMarkTM microplate reader. Protein concentration was 
determined by standardizing each well to the BSA protein concentration curve. 
The curve was developed by graphing absorbance as the x-axis and the BSA 
standard concentrations as the y-axis. A linear regression line was drawn with y 
= m × x, where y= protein concentration in mg/mL, m = slope and x = 
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absorbance. The mean blank was subtracted from all sample values and the total 
protein content was calculated by multiplying the volume of the sample (0.3mL) 
by the protein concentration in mg/mL.  
Calcium Determination. The calcium assay was performed with the same 
RIPA collected samples from the Lowry assay. A standard curve was developed 
from the 10 mg/mL calcium stock solution for 8 concentrations in serial dilution 
that ranged from 0.0 - 0.03 mg/mL Ca2+. 25µL of each calcium standard curve 
concentration and RIPA collected lysates were placed into a 96-well plate. 
Additionally, 75µL of Arsenazo III was added to each 96-well plate and 
absorbance was read at 655nm with a Bio-rad iMarkTM microplate reader. The 
calcium standard curve was drawn based off the values of the calcium standard 
concentrations as the y-axis and absorbance as the x-axis. A linear regression 
line (y = m × x) was drawn through 0 intercept where the slope was m, 
absorbance as the x, and calcium concentrations in mg/mL as the y. The blank 
value was subtracted from the sample values and total calcium content of each 
sample was calculated by the volume of the sample multiplied (0.3mL) by the 
calcium concentration in mg/mL. The total calcium content was normalized to the 
total protein content that was measured with the Lowry assay. The untreated 
wells were averaged and set to 100 percent and all values were calculated as 
percentage of the untreated average. The mean and the standard deviation for 
all test chemical concentrations were also calculated. The data was graphed with 
the x-axis as the test chemical concentrations from low to high (left to right) and 
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the y-axis as the percentage.   
Classification of Tested Chemicals in the EST Biostatistical Model 
 The embryotoxic potential of the test chemical was calculated from the 
IC50 and ID50 values. The IC50 and ID50 values were determined by graphical 
estimation. The ID50 for the differentiation endpoint (hESCs) was put into relation 
to the cytotoxicity endpoints (IC50 hESC and IC50 hFF) by insertion into three 
linear discriminant functions.  
 
I: 5.9157 log10(IC50 hFF) + 3.500 log10(IC50 hESC) − 5.307
IChFF−ID50 hESC
IC50 hESC
− 15.72  
II: 3.651 log10(IC50 hFF) + 2.394 log10(IC50 hESC) − 2.033
IChFF−ID50 hESC
IC50 hESC
− 6.85      
III: −0.125 log10(IC50 hFF) − 1.917 log10(IC50  hESC) + 1.500
IChFF−ID50 hESC
IC50 hESC
− 2.67   
 
A chemical was classified as non-embryotoxic agent when values 
determined I>II and I>III (class I), as a weak embryotoxic agent (class II) if II>I 
and II>III, and a strong embryotoxic agent (class III) when  III>I and III>II.  
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CHAPTER THREE 
PREVIOUS DATA 
 
Osteogenic Protocol 
Human ESCs were grown on matrigel coated plates and fed with mTESR 
until they reached 70% confluency. Upon reaching confluency the media was 
replaced with control differentiation media largely composed of Fetal Bovine 
Serum (FBS) and Basal Medium Eagle Medium (DMEM). Cells were grown in 
control differentiation media until day 5 when the medium was supplemented with 
osteogenic factors 1-alpha,25 (OH)2 (Vitamin D3), ascorbic acid (AA), and beta-
glycerophosphate (BGP) (Figure 4A).  
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Figure 4. Determination of Osteogenic Differentiation and Identity. (A) Schematic of the 
osteogenic differentiation protocol. (B) Immunostaining with an osteocalcin antibody reveals 
presence of bone matrix in the vicinity of black deposits. Alizarin Red S staining detected calcium 
ions in the same areas. (C) Quantitative measurement of deposited calcium over time, n=5 
independent replicates ± SD, *P<0.05 Student’s t test compared to d0. (D) Quantitative mRNA 
analysis of RUNX2, SATB2 and OCN, normalized to GAPDH (n=3 independent samples ± SD), 
*P<0.05 One-Way ANOVA over day 0. Triplicates were pooled for RT-PCR analyses of the 
osteocyte genes CAPG and DESTRIN (inset). Unpublished data.  
 
 
Osteocalcin, a protein that is secreted by osteoblasts into the extracellular 
matrix of bone was identified in cultures. Likewise, Alizarin Red S further 
confirmed the calcification of the ECM another hallmark as the result of 
osteoblast formation (Figure 4B). Calcium deposition were shown to increase 
throughout 30 days of the osteogenic differentiation (Figure 4C). Quantitative 
mRNA confirmed the presence of RUNX2, an early osteogenic marker that 
controls other osteogenic markers, SATB2 an osteogenic progenitor marker, and 
OCN a mature osteoblast marker (Figure 4D). CapG and Destrin presence are 
indicative that osteoblasts are maturing into osteocytes.  
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Tobacco Exposure and Osteogenesis 
The lab next tested the effects of tobacco on osteogenic differentiation. 
Among the tested products were two conventional cigarettes, one additive-free 
variety and two so-called ‘Light’ cigarettes. Both mainstream (MS) smoke, which 
is what the smoker inhales, and side-stream (SS) smoke, which burns off the tip 
of the cigarette, were tested.  The conventional products caused no significant 
change in cell viability or calcification for any of the tested concentrations (Figure 
5A). In contrast, the conventional side stream smoke showed a decrease in cell 
viability and calcification, with both curves overlapping (Figure 5B), suggesting 
that the differentiation defect was caused by the cytotoxicity of the product. 
While the additive-free cigarette smoke extract behaved similarly as the 
conventional products did, the two harm-reduction cigarettes exhibited very 
different patterns. Harm-reduction SS smoke caused a significant decrease in 
calcification already at sub-toxic concentrations (Figure 5D). This poses a 
significant issue for in utero exposures since it implies that surviving cells are 
defective potentially resulting in developmental abnormalities for the fetus during 
pregnancy. This truly teratogenic effect was seen also in MS smoke of the harm-
reduction brands, albeit at high concentrations. These results let us conclude that 
harm-reduction cigarettes may be more detrimental to the developing fetus than 
conventional cigarettes.  
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Figure 5. Determining Osteogenic Toxicity in Conventional and Light Camel Cigarettes. Human 
ESCs were treated with different concentrations of MS smoke solution and scored for effects on 
calcium deposit using Arsenazo III and on viability using an MTT assay. A) Camel MS smoke 
solution. B) Camel SS smoke solution. C) Camel Blue MS smoke solution. D) Camel Blue SS 
smoke solution. Each data point is the mean of three independent experiments ± standard 
deviation. ΔP<0.05 = lowest concentration significantly below the untreated control in the calcium 
assay determined by One-Way ANOVA. *P<0.05 = lowest concentration significantly below the 
untreated control in the MTT assay on H9 hESCs determined by One-Way ANOVA. hESC, 
human embryonic stem cell; MS, mainstream; MTT, mitochondrial dehydrogenase activity assay; 
SS, side-stream. Unpublished data.  
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CHAPTER FOUR 
RESULTS 
 
ToxPI Development and Production 
Of the 93 chemicals on the FDA’s tobacco products and smoke HPHC list 
only 46 were found in the Toxicity Forecaster database. With the intention of 
making ToxPI parameters specific to osteogenesis a variety of genes necessary 
for bone development were examined in the Toxicity Forecaster. Genes such as 
Frzzld, CatB, and FoxO paramount to osteogenesis were incomplete for each of 
the remaining 46 tobacco constituents. Using incomplete data sets introduced 
large margins of errors in the ToxPI prediction model and were not useful for 
meaningful analysis. Other chemical properties such as oral absorption was 
absent for the targeted chemicals. To use ToxPI as a useful prioritization tool it 
was then decided to use biological processes as the driving data parameter. This 
shortened our remaining HPHC list of 46 chemicals to 17. Biological processes 
are normal functions that all cells must undergo to be viable. Though these 
parameters are broad and not osteogenically specific, their inclusion would be 
appropriate as any perturbations of these biological processes could alter cell 
fate and differentiation capabilities of hESCs.24  
Furthermore, additional parameters were implemented. Row 1 data on the 
reformatted excel sheet was given a value of 1 to ensure equal weight among 
assays and biological processes. Each assay was also renamed in Row 5 to its 
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corresponding biological process. To predict long term exposure 24, 48, and 72-
hour assays were used where shorter duration assays were disregarded. All 
assays were further optimized to include human cell lines for a variety of tissues 
and non-human animal data was excluded to avoid species-to-species 
differences in chemical sensitivities. Each biological process was given its own 
unique color (Figure 6) and scaling was applied to each of data sets to ensure 
that lower AC50 values were indicative of bigger pie charts where larger values 
produced smaller visualizations. Out of the 17 ToxPI predictive pie charts 8 
chemicals generated ToxPI positive results where 9 of the chemicals did not 
produce a visualization (Figure 7).  
 
 
Biological Process Data 
Type 
Weight Components 
Cell Proliferation (Red) Assay 1 30 
Cell Death (Black) Assay 1 27 
Oxidative Phosphorylation 
(Yellow) 
Assay 1 8 
Mitochondrial Depolarization 
(Purple) 
Assay 1 5 
Cell Morphology (Green) Assay 1 2 
 
Figure 6. ToxPI Integrated Components. Each biological process was given its own pie chart slice 
(5) based off assay data and had equal weight.  In total, 72 assays encompassed all five 
biological process slices. Each slice was then given its own color; Cell Proliferation (Red), Cell 
Death (Black), Oxidative Phosphorylation (Yellow), Mitochondrial Depolarization (Purple), and 
Cell Morphology (Green).  
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Figure 7. ToxPI Generated Charts. ToxPI charts were generated for 17 chemicals using 72 in 
vitro assays across 5 biological processes. Benz(a)anthracene (3.251), Benzo(b)fluoranthene 
(2.137), Catechol (2.15), Napthalene (1), Nitrobenzene (.457), Coumarin (.451), Acetamide 
(.391), Quinoline (.107), and N-Nitrosodimethylamine (.102) had designated “hits” and produced 
positive ToxPi values (0< X). The remainder of the chemicals 2,6 Dimethylaniline, Acrylamide, 
Nitrososodiethylamine, Nicotine, Cotinine, Phenol, o-cresol, p-cresol, and Urethane had ToxPI 
predicted null effects (X=0). 
 
 
To compare the predicted value assigned to each chemical using ToxPI 
with its actual cytotoxicity and skeletal toxicity, we next chose a set of chemicals 
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to test in vitro using the human EST that the lab had established previously. We 
chose these chemicals at random from ToxPI positive and ToxPI negative 
chemicals. The randomly selected ToxPI positive chemicals were BAA with the 
highest ToxPI predictive score of 3.717, catechol with the second highest score 
of 2.982, coumarin, which received the fourth highest score of 0.451, and 
quinolone, whose penultimate ToxPI positive score value was 0.107. The 
randomly selected ToxPI null chemicals were nicotine (0), cotinine (0), 
acrylamide (0), and urethane (0) (Figure 7).  
 
Human EST In Vitro Data for ToxPI Positive Chemicals 
BAA and Catechol’s hFF cell line did not exhibit a loss in cell viability in 
the same range as their H9 counterparts (Figure 8). Quinoline’s hFF cell viability 
was reduced at concentrations a hundred-fold higher than their H9 counterparts 
whereas coumarin’s hFF cell viability was reduced within the same range as its 
H9 immature cell line. All four ToxPI constituents showed dose response curves 
of H9 cell viability and calcification following similar trends, it is believed that the 
decrease in calcification is an attributed consequence of the overall reduction in 
viable cells. BAA was calculated to have a 200 µg/mL H9 hESC ID50/IC50, 
catechol’s H9 hESC ID50/IC50 was 0.1 µg/mL, coumarin received a H9 hESC 
ID50/IC50 of 20 ug/mL, and quinoline’s H9 hESC ID50/IC50 was 5.5 µg/mL. (Figure 
8). All tested ToxPi charts were able to predict immature H9 cytotoxicity, though 
the potency of the compound could not have been assessed by looking at the 
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size of each predicted pie chart.  
When assessing the average assay hit rate for each of the ToxPI tested 
chemicals, the ToxPI score and size for each pie chart varied between chemicals 
as did the average micromolar concentration for each chemical constituent. This 
discrepancy became less apparent when the assay hit rate was converted from 
micromolar into micrograms per microliter (Figure 9). Interestingly, the predictive 
value of each assay hit rate in µg/mL was relatively close to our in vitro H9 hESC 
ID50/IC50 (Figure 9). 
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Figure 8. Determination of Skeletal Teratogenicity for ToxPI Positive Chemicals. Dose response 
curves for ToxPI positive Benz(a)anthracene, Catechol, Coumarin, and Quinoline. The three 
endpoints for the osteogenic EST; Cell Viability (MTT) of H9 hESC and hFF, and differentiation 
potential via assessment of calcium deposits are shown. 
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 BAA Coumarin Catechol Quinoline 
AC
50
 hit µM Average 47.04 62.51 14.70 67.80 
AC
50
 hit µg/mL 
Average 
10.73 9.86 1.16 8.76 
H9 hESC ID
50
/IC
50  
µg/mL 
200 ± 76 20 ± 10 0.01 ± .005 2 ± 1.5 
 
Figure 9. Toxicity Forecast Data Averages and In Vitro H9 hESC ID50/IC50 µg/mL Values. The 
average assay hit value in µM (AC50) values for each tested ToxPI positive constituent obtained 
from the Toxicity Forecaster database. The AC50 in µM for was then converted into µg/mL in 
comparison to the H9 hESC ID50/IC50 values calculated from the in vitro osteogenic screen.  
 
 
Human EST In Vitro Data for ToxPI Negative Chemicals 
Four ToxPI null chemicals (nicotine, cotinine, urethane, and acrylamide) 
were also taken through the osteogenic EST (Figure X). ToxPI predicted null 
effects matched in vitro screen data as urethane, cotinine, nicotine, and 
acrylamide exposure did not inhibit cell viability for either the H9 and hFF cell 
lines for all tested concentration ranges (Figure 10). Likewise, H9 hESC 
differentiation potential was not altered in the same concentration range for 
urethane, cotinine, and acrylamide. However, a notable decrease in calcification 
(Figure 10) was seen in the higher concentrations of nicotine exposure.  
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Figure 10. Determination of Skeletal Teratogenicity for ToxPI Null Chemicals. Dose response 
curves for ToxPI null Nicotine, Cotinine, Acrylamide, and Urethane. The three endpoints for the 
osteogenic EST; Cell Viability (MTT) of H9 hESC and hFF, and differentiation potential via 
assessment of calcium deposits are shown. 
 
 
Toxicity Predictions Based on the EST Biostatistical Model 
All tested chemicals hFF IC50 and H9 hESC ID50/IC50   values were 
incorporated into the EST bio-statistical model as outlined in classification of 
tested chemicals in the EST Bio-Statistical Model. All in vitro tested ToxPI 
positive pie charts were classified as weakly or strongly embryotoxic, whereas all 
in vitro tested ToxPI null predicted chemicals were classified as non-embryotoxic. 
Coumarin and BAA were classified as weakly embryotoxic where catechol and 
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quinoline received a strongly embryotoxic compound status (Figure 11). The 
discrepancy between strongly and weakly embryotoxic seemed to have been 
attributed to the IC50 value found for the cell viability in fully differentiated hFFs in 
relation to those found with the undifferentiated H9 cell line.  
 
 
Chemical 
Name 
ToxPI 
Prediction 
hFF (IC50) 
Cytotoxicity  
hESC (IC50) 
Cytotoxicity 
hESC (ID50) 
Differentiation 
EST 
Classification 
BAA + — 200 ± 76 200 ± 76 
Weakly 
Embryotoxic 
Catechol + — 0.1 ± 0.05 0.1 ± 0.05 
Strongly 
Embryotoxic 
Coumarin + 65 ± 26 20 ± 10 20 ± 10 
Weakly 
Embryotoxic 
Nicotine - — — 0.32 ± 3 
Non-
Embryotoxic 
Cotinine - — — — 
Non-
Embryotoxic 
Urethane - — — — 
Non-
Embryotoxic 
Quinoline + 100 ± 85 2 ± 1.5 2 ± 1.5 
Strongly 
Embryotoxic 
Acrylamide - — — — 
Non-
Embryotoxic 
Figure 11. Toxicity Classification in the EST Biostatistical Model. ToxPI predictions are listed 
along H9 and hFF cell viability in addition to differential potential of H9 hESCs into osteoblasts. 
The following ID50 and IC50 were incorporated into a bio-statistical model and classified as either 
Non-Embryotoxic, Weakly Embryotoxic, or Strongly Embryotoxic. 
 
 
 
Third Hand Smoke Constituents 
Third hand smoke (THS) constituents are the residue and particulate 
matter that persists long after a cigarette has been ignited. THS lifespan can 
range from several weeks to months and because of its interaction with the 
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environment can be more volatile as it ages. THS remain an understudied 
component of tobacco products and many of the chemical constituents in the 
HPHC largely list mainstream and side stream components. We found it of great 
importance to study the individual constituents that make up THS through our 
EST osteogenic protocol. The chemicals that were selected have been shown to 
persist in carpet after several months.37 In addition, these selected THS 
constituents are on the FDA’s HPHC list and makes them prime candidates to be 
tested. These constituents however were not included in the ToxPI analysis due 
to a lack of sufficient assay availability in the Toxicity Forecaster database.  
Nicotelline’s H9 hESC cell viability decreased in a similar trend with 
calcification, this similarity in dose response curves is likely a consequence from 
reduction of viable cells. Thus, an h9 hESC IC50 of >200 µg/mL was estimated. 
The adult line also decreased in the same concentration range and produced an 
hFF IC50 of >200 µg/mL.  NFN, NAT, and NNK did not display cytotoxicity in the 
adult hFF or immature H9 cell line (Figure 12). Differentiation potential into 
osteoblast was also not inhibited in the same concentrations range for the tested 
chemicals. Though the hFF cell viability remained inert for NNA through all 
concentrations, a significant reduction in H9 cell viability and calcification was 
seen at the highest tested concentration of (4.8 x 10-4 µg/mL) (Figure 12). When 
grouped in ternary combination THS constituents Nicotelline, NNA, and NNK cell 
viability and calcification was further reduced than each chemical constituent 
could induce individually (Figure 13). 
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Figure 12. Determination of Skeletal Teratogenicity for Third Hand Smoke Constituents. Dose 
response curves for THS constituents Nicotelline, (R,S)-N-Nitrosoanatabine (NAT), N-
Formylnornicotine (NFN), 4-(methylnitrosamino)-4-(3-pyridyl) butanal (NNA), and 4-(N-Methyl-N-
nitrosamino)-1-(3-pyridyl)-1-butanone  (NNK). The three endpoints for the osteogenic EST; Cell 
Viability (MTT) of H9 hESC and hFF, and differentiation potential via assessment of calcium 
deposits are shown. 
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Figure 13. Cell Viability and Calcification of a Ternary Combination of THS Constituents. Three 
THS constituents; Nicotelline, NNA, and NNN were subjected in tandem to our osteogenic 
protocol. H9 hESC cell viability (MTT) and differentiation potential via assessment of calcium 
deposits are shown. 
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CHAPTER FIVE 
DISCUSSION 
 
ToxPI Predictions and In Vitro Data 
Toxcast iCCS has over 11,000 chemicals and 21,000 assays available, 
though there was a lack of endpoints and gene targets relating to osteogenesis 
available in the online database. We decided to use biological processes to help 
predict cytotoxicity as the partition between cytotoxicity and teratogenicity is 
indistinguishable in vivo.24 Other factors were thought to be included in addition 
to using biological processes’ AC50 values (Assay hit rate) but incorporating LogP 
values38 and Z-scores39 may have not corrected potential false negatives and 
have been shown to remove pie charts that reflected true positives in ToxPI 
predictions.  
 The selected data used from Toxcast across the 72 assays and 5 
biological processes were heavily geared towards cytotoxicity.  This is due to 52 
of the 72 biological processes’ assays exclusively measuring cell proliferation or 
cell death. The assays excluded non-human cell types and multitude of cell 
lineages ranging from Human Embryonic Kidney (HEK) cells to umbilical vein 
endothelium. With this range in cell types it was likely that the H9 hESC IC50 
values that were obtained in our in vitro screen would fall in the range of AC50 
values that were available in the Toxcast. In addition to cell types, the chosen 
assay time endpoint excluded more short-term assays such as a one-hour 
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exposure time to focus on potential cytotoxic and teratogenic effect that are part 
of long-term exposure.  The assays tested range from 0 µM to 1000 µM. The 
maximum threshold of 1000 µM to micrograms per milliliter can be readily 
converted by looking at a chemical’s molecular weight. The eight tested 
chemicals max threshold ranged from 60 µg/mL to 228 µg/mL. Without 
consideration for max thresholds ToxPI predicted null pie charts could seemingly 
provide false negatives for chemicals whose cytotoxic and teratogenic effects are 
induced above the predictive threshold.  
Acrylamide’s ToxPI null prediction were for concentrations up to 71 µg/mL 
where cytotoxic and differentiation inhibition was seen at concentrations greater 
than 100 µg/mL (data not shown). Likewise, urethane’s ToxPI null predicted chart 
were for concentrations up to 89 µg/mL where cytotoxic effects were seen at 
extreme exposure concentrations (1000 µg/mL, data not shown).   
The in vitro tested ToxPI positive chemicals (BAA, Coumarin, Catechol, 
Quinoline) all varied in the number of “hits” for the incorporated assays. BAA and 
catechol had the highest amount of assay “hits” with catechol having slightly 
more than BAA. BAA’s higher ToxPI score was predominantly based on its ability 
to have hits in all five of the biological process in addition to having the most 
sensitive AC50 value. The average AC50 value for each tested ToxPI positive 
constituent ranged from 14 µM- 67 µM, however, when converted into 
micrograms per microliter this discrepancy diminished, and all ToxPi positive 
tested chemicals fell within a 10 microgram per microliter range of each other. 
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This small threshold could explain why ToxPI positive chemicals H9 hESC IC50 
values were similar despite having different ToxPI predictive chart sizes. This 
would also suggest that our ToxPI positive visualizations are more an indicator 
on the likelihood of producing a cytotoxic event within a given concentration 
range rather than a ranking system for potent cytotoxic constituents.  
There was an uncanny consistency between the Toxcast data that was 
implemented into the ToxPI GUI. For all ToxPI positive predictive charts there 
was not a reliable assay that provided a hit among the predictive constituents 
even among each of the biological processes. This variability did not inhibit the 
ability to predict cytotoxic effects. Though, it would be beneficial to include 
validated assays such as the MTT for cell death or Bromodeoxyuridine (BrdU) for 
cell proliferation. Because the Toxicity Forecaster data was generated using 
high-throughput screening these may not be feasible options as most of the 
assays were luminescence based and automated, but including data from these 
assays when available, as well as incorporating data from previous studies could 
provide stronger confidence in ToxPI predictions. The incorporation of previously 
reported data in conjunction with Toxcast data has been successful in ranking 
chemical constituents based on ability to reduce gill size in zebrafish.33   
Our only ToxPI null predicted chemical to produce a half-maximal value 
was the most famous chemical constituent in tobacco and tobacco related 
products: nicotine. Nicotine is a powerful neurotoxin that interacts with 
acetylcholine receptors and can alter brain development, though its effects are 
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largely dependent on duration, dose, and habitual use.40-42 Nicotine has been 
shown to have dose-dependent inhibition on cell viability and proliferation for a 
variety of tissues43 though there are conflicting studies regarding the ability of 
nicotine to impede cell viability. However, in non-neural cells it can activate 
antagonistic cell survival and death pathways, though the precise mechanism of 
choosing one biological process over another is not clear.44 This can resolve the 
discrepancy between contradicting results of the cytotoxicity associated with 
nicotine and explain why both our adult and immature cell viabilities were 
maintained through all tested concentrations.  
In contrast, the role nicotine plays in osteogenesis is transparent as its 
dose-dependent inhibition is documented in a variety of studies.45-47 Though 
ToxPI had a variety of parameters to predict the cytotoxicity of nicotine, 
osteogenic endpoints were not able to be integrated into the ToxPI predictive 
model. Therefore, differentiation inhibition did not produce a visualization on the 
ToxPI chart of nicotine in contrast to our EST in vitro data.  
 
EST Biostatistical Model Versus ToxPI Predictions 
All in vitro tested chemicals were incorporated into the EST bio-statistical 
model. The model then classified each of the compounds based on their ability to 
induce embryotoxicity. This classification gave insight into little known effects of a 
chemical’s exposure. Alongside each chemical in the FDA’s HPHC list are 
categories that classify each chemical as a Carcinogen (CA), Respiratory 
53 
 
Toxicant (RT), Cardiovascular Toxicant (CT), Reproductive or Developmental 
Toxicant (RDT), or Addictive (AD).48 All tested chemicals were given a CA 
classification on the HPHC list except for nicotine, that was classified as both an 
AD and RDT. Our data suggests that in addition to a CA classification both 
quinoline and catechol are RDTs. This is especially alarming as our H9 hESC 
IC50 catechol levels can be reasonably reached from smoking 1-2 cigarettes.49 
Nicotine was calculated to have an H9 hESC ID50 value with no changes in cell 
viability for the immature and mature cell lines but was listed as a non-
embryotoxic compound. Embryotoxicity in the EST is defined as the adverse 
effects on the embryo expressed as embryonic cell death to one or more body 
systems that can be expanded to maternal health. This is a limitation of the EST, 
though it can classify embryotoxic effects the EST biostatistical model cannot 
classify chemicals who are teratogenic at sub-toxic levels.50  
ToxPI predicted AC50 and in vitro h9 hESC’s IC50 values corresponded well 
with numerous in vivo tests. Coumarin’s toxicity in zebrafish51 and Xenopus52 
provided half-maximal activity values for viability that were adjacent to both our 
own hESC and hFF IC50. Likewise, quinoline is reported to induce a variety of 
malformations and toxicity between 29-95 ug/mL depending on the 
developmental stage of Xenopus53 where the median lethal dose for other 
aquatic species has been reported to be 11 ug/mL.54 Catechol had a variety of 
animal models55,56 with toxic concentrations similar to our own and it 
corroborated with other independent in vitro data.57 BAA also had exposure 
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values that resulted in the death of zebrafish larvae slightly lower than our 
results.58  
 For our tested ToxPI null chemicals none of our concentrations were 
detrimental to cell viability of our H9 hESC. Cotinine levels in blood of chronic 
smokers is 500 ng/mL, light smokers are from 30-50 ng/mL, whereas 1-10 ng/mL 
and concentrations below the 1 ng/mL threshold are regarded as low.59 Our 
study tested far above these biologically relevant thresholds and found no 
inhibitory effects. Urethane (ethyl carbamate) in other toxicological studies only 
induced a reduction in cell viability at excessively high concentrations.60 These 
concentrations however are a thousand times greater than can be encountered.61 
Acrylamide exposure for rat and murine NR-50 levels (midpoint toxicity)62 were 
relatively close to our IC50 values when excluding ToxPI maximum threshold for 
both H9 and hFF cells. Acrylamide’s cytotoxicity in this concentration range 
seems to be prevalent for both in vitro and in vivo studies using a variety of 
animal models.63,64 Though the estimated dietary concentration of acrylamide is 
around 1µm for the average adult65 and additional acrylamide exposure in 
cigarettes raises the dietary levels by only three times the amount.66 Though our 
data suggests a differentiation inhibition capability of nicotine during 
osteogenesis these levels are not biologically relevant as they are not achieved 
in arterial blood67 after smoking and in extreme cases are as high as 0.1 
µg/mL.68-70                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
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Overall, ToxPI predictions based on the parameters we have set forth are 
likely indicators of reduced H9 cell viability and can partition between chemicals 
that induce and do not induce cytotoxic events when tested in ToxPI predictive 
thresholds. ToxPI may lack sensitivity to detect sub-toxic effects, but as 
implemented in our study lacks a predictive component for osteogenesis. 
Though, our parameters may be altered to incorporate genes and pathways that 
can predict the inhibition of other differentiation processes that are available on 
the Toxicity Forecaster database. There are potential pitfalls that can arise from 
the ToxPI system, however, with an ever-growing database and subsequent 
improvements it can be a useful resource in assessing the ability of a chemical to 
impact early embryonic development.  
     
THS EST and Combination Testing 
THS as a new emerging threat to human health has garnered much 
attention in the last decade.71 The main source of THS is attributed to nicotine as 
it is absorbed by the surface and reacts with nitrous acid (HONO) species in 
addition to ultraviolet light and other ambient species.72 However, this is not 
applicable to all THS constituents as NAT is a non-nicotine derived tobacco 
constituent that is primarily derived from anatabine and anabasine. THS extracts 
from carpets exposed to cigarette smoke have confirmed the presence of NNK, 
NNA, NAT, and NFN.37 Each of the chemicals were found to have increased 
concentrations as smoking persisted and found the highest concentrations of 
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THS constituents were found at 12 months of exposure. Surprisingly, THS 
constituents are not exclusive to cigarette combustion. Studies have shown that 
NNN and NNK concentrations were higher in homes occupied by smokeless 
tobacco users than in tobacco-free homes.73 This is alarming as THS levels 
seem to increase with the use of tobacco products regardless of how the 
products is consumed. This also raises new concerns as cleaning methods such 
as vacuuming are ineffective in the removal of THS constituents from the 
environment.  
Early efforts into the potential health outcomes of THS focused on 
genotoxicity and carcinogenicity. These early studies reported THS constituents 
NNN and NNK to induce DNA damage in human cells at biologically relevant 
concentrations and subsequently led to their classification as carcinogens.74 
Furthermore, in vivo studies have shown THS to reduce the weight and immunity 
of mice in the absence of carcinogenicty.75 There have been several attempts to 
assess the toxicity of THS constituent’s in vitro as THS terry cloth extracts have 
demonstrated the ability to inhibit mouse neural stem cell survival as well as 
mature human fibroblast.76 NNK has also demonstrated the ability to inhibit lung 
tissue repair, though there are no experiments that have solely focused on a 
specific developmental process. To our knowledge we are the first to test the 
toxicity of NFN and NAT, and Nicotelline using a differentiation protocol.   
Three of our THS constituents (NAT, NFN, NNK) did not hinder cell 
viability or differentiation in the tested concentrations. This suggests that the 
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screened THS constituents may be non-embryotoxic compounds. Individually, 
the tested THS constituents themselves may not be cytotoxic but there is strong 
evidence that THS possess combinatorial effects. For example, NNK 
synergistically reacts with NNN to produce deleterious effects increasing their 
capability to induce double strand DNA breaks.77 Like many chemical 
concoctions, THS effects appear to be dose-dependent but its effects on various 
development processes are still not clear. NNA produced a decrease in cell 
viability for hESC suggesting embryotoxicity at relatively low concentrations. This 
inhibition of cell viability is within range of NNA concentrations found in the 
homes of continuous smokers, where these reported findings gave NNA 
concentrations modest estimations.78  
Further studies should be done to assess the synergistic effects of THS 
during embryogenesis. Our lab has done early experiments that suggest many 
chemicals constituents exhibit a stronger effect on development when used in a 
ternary combination. Though the full spectrum of the ability of THS to cause 
potential harm during pregnancy and the early years of childhood are not fully 
known, we have demonstrated that the THS constituent NNA poses a potential 
health concern other than carcinogenicity.  
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CHAPTER SIX 
CONCLUSIONS 
 
A Framework for Toxicity Testing in the Future 
Narrowing down the primary drivers of the chemical mixture that 
encompasses tobacco products and smoke remains a large challenge. This 
study has found that using the ToxPI program in conjunction with Toxcast data 
can partition cytotoxic constituents from those that will produce no harm within 
their predictive range. This is especially useful as many tobacco constituents are 
encountered in the agricultural and pharmaceutical sector. Furthermore, because 
our parameters inserted into the ToxPI GUI were broad, they can be applied to 
various products who are made up of a concoction of chemicals and is not limited 
to those chemicals in tobacco products and smoke. Though the parameters 
chosen to generate the ToxPI charts were not specific to the osteogenic lineage, 
their testing in a well-established protocol was a recapitulation of osteogenic 
development during gastrulation. With the assimilation of Toxcast data in its 
infancy, the database has the potential to grow and could have data available in 
the future to help predict osteogenic maldevelopment specifically as seen 
currently with other target tissues. 
With the limitations of available data for HPHC chemicals and the 
emergence of a new potential threat in the form of THS we found it of great 
importance to test constituents through the osteogenic protocol. Our data 
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suggests that the tested THS constituents individually are not all cytotoxic but 
could still pose great harm in tandem with other tobacco related chemicals. 
Overall, because there are many routes of exposure to tobacco products even 
among non-users, it is of importance to incorporate data when available from 
high-throughput sources to make conclusions about the toxicity and 
developmental effects a chemical constituent can produce.  
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